VERA — Vera Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Vera Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	53.7	79.7	115	161	641
Net Total Receivables	0.052	—	—	—	3.77
Prepaid Expenses
Total Other Current Assets
Total Current Assets	54.3	82.5	126	172	651
Net Property, Plant And Equipment	0	—	5.22	3.04	4.33
Long Term Investments
Other Long Term Assets
Total Assets	54.6	83.7	131	176	656
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.41	7.69	25.6	22.3	25.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.33	14.2	54.5	73.9	78.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	50.2	69.6	76.9	102	577
Total Liabilities & Shareholders' Equity	54.6	83.7	131	176	656
Total Common Shares Outstanding